Mulhall J Connor, Ireland Kayla E, Byrne John J, Ramsey Patrick S, McCann Georgia A, Munoz Jessian L
Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Division of Fetal Intervention, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA.
Department of Obstetrics & Gynecology, University of Texas Health Sciences Center at San Antonio, San Antonio, TX 78229, USA.
Medicina (Kaunas). 2024 Apr 22;60(4):677. doi: 10.3390/medicina60040677.
: Placenta accreta spectrum (PAS) disorders are placental conditions associated with significant maternal morbidity and mortality. While antenatal vaginal bleeding in the setting of PAS is common, the implications of this on overall outcomes remain unknown. Our primary objective was to identify the implications of antenatal vaginal bleeding in the setting of suspected PAS on both maternal and fetal outcomes. : We performed a case-control study of patients referred to our PAS center of excellence delivered by cesarean hysterectomy from 2012 to 2022. Subsequently, antenatal vaginal bleeding episodes were quantified, and components of maternal morbidity were assessed. A maternal composite of surgical morbidity was utilized, comprised of blood loss ≥ 2 L, transfusion ≥ 4 units of blood, intensive care unit (ICU) admission, and post-operative length of stay ≥ 4 days. : During the time period, 135 cases of confirmed PAS were managed by cesarean hysterectomy. A total of 61/135 (45.2%) had at least one episode of bleeding antenatally, and 36 (59%) of these had two or more bleeding episodes. Increasing episodes of antenatal vaginal bleeding were associated with emergent delivery ( < 0.01), delivery at an earlier gestational age (35 vs. 34 vs. 33 weeks, < 0.01), and increased composite maternal morbidity (76, 84, and 94%, = 0.03). : Antenatal vaginal bleeding in the setting of PAS is associated with increased emergent deliveries, earlier gestational ages, and maternal composite morbidity. This important antenatal event may aid in not only counseling patients but also in the coordination of multidisciplinary teams caring for these complex patients.
胎盘植入谱系障碍(PAS)是与孕产妇严重发病和死亡相关的胎盘疾病。虽然PAS情况下产前阴道出血很常见,但其对总体结局的影响仍不清楚。我们的主要目标是确定疑似PAS情况下产前阴道出血对孕产妇和胎儿结局的影响。
我们对2012年至2022年在我们的卓越PAS中心接受剖宫产子宫切除术分娩的患者进行了病例对照研究。随后,对产前阴道出血事件进行量化,并评估孕产妇发病的组成部分。采用了一种手术发病率的孕产妇综合指标,包括失血≥2升、输血≥4单位、入住重症监护病房(ICU)以及术后住院时间≥4天。
在此期间,135例确诊的PAS病例通过剖宫产子宫切除术进行处理。共有61/135(45.2%)的患者产前至少有一次出血事件,其中36例(59%)有两次或更多次出血事件。产前阴道出血事件增多与紧急分娩相关(<0.01)、孕周提前(35周与34周与33周相比,<0.01)以及孕产妇综合发病率增加相关(分别为76%、84%和94%,=0.03)。
PAS情况下的产前阴道出血与紧急分娩增加、孕周提前以及孕产妇综合发病率增加相关。这一重要的产前事件不仅有助于为患者提供咨询,还有助于协调照顾这些复杂患者的多学科团队。